Organization · Venture Capital
Laplace Partners Inc.
Laplace Partners Inc. is a South Korea-based early-stage venture capital firm specializing in AI and bio-healthcare investments. The firm focuses on supporting startups and growth-stage companies with innovative solutions.
Overview
What Laplace Partners Inc. does
What Laplace Partners Inc. is
Laplace Partners Inc. is a South Korea-based early-stage venture capital firm specializing in AI and bio-healthcare investments. The firm focuses on supporting startups and growth-stage companies with innovative solutions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find Laplace Partners Inc. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Laplace Partners Inc. as a funder
Investment thesis
Invests in groundbreaking AI and bio-healthcare companies transforming complex challenges into innovative solutions.
Focus narrative
Laplace Partners invests in early to growth-stage companies, particularly in the AI and bio-healthcare sectors. Their investment strategy is centered on identifying innovative solutions that address complex challenges, with a commitment to supporting portfolio companies through their growth journeys.
Value beyond capital
Laplace Partners provides deep biotech and IT expertise beyond capital, actively supporting portfolio companies through challenging growth phases.
Terms and economics
- Typical check
- $100,000–$1,000,000
- Sweet spot
- $500,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Growth Equity
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 100
Portfolio context
Laplace Partners has a diverse portfolio that includes notable companies such as HITS, which specializes in AI-driven drug discovery and has formed partnerships with major firms like LG Chem; Arbormed, focused on pharmaceutical licensing; Ingenium Therapeutics, which is developing treatments for acute myeloid leukemia; and Avomed, a drug developer with a stable revenue track record.
Common questions
What to know about Laplace Partners Inc.
Upseed classifies Laplace Partners Inc. under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.